PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients by Nagata Yoichi, Lan Keng-Hsueh, Zhou Xiaoyan, Tan Ming, Esteva Francisco J, Sahin Aysegul A, Klos Kristine S, Li Ping, Monia Brett P, Nguyen Nina T, Hortobagyi Gabriel N, Hung Mien-Chie, Yu Dihua in Cancer cell (2004).

[PMID: 15324695] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.